William Blair Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-165,494
Closed -$5.17M 447
2017
Q2
$5.17M Sell
165,494
-98,432
-37% -$2.84M 0.02% 349
2017
Q1
$6.5M Sell
263,926
-16,530
-6% -$388K 0.02% 327
2016
Q4
$7.11M Sell
280,456
-190,544
-40% -$4.23M 0.03% 329
2016
Q3
$9.35M Buy
471,000
+28,506
+6% +$498K 0.04% 318
2016
Q2
$6.31M Sell
442,494
-4,222
-0.9% -$64.6K 0.03% 337
2016
Q1
$6.93M Buy
446,716
+30,527
+7% +$438K 0.03% 325
2015
Q4
$7.18M Buy
416,189
+11,387
+3% +$165K 0.03% 317
2015
Q3
$4.93M Buy
+404,802
New +$5.19M 0.01% 798

Other funds holding LMAT

William Blair Investment Management's LMAT Position: Q3 2017 in Review

William Blair Investment Management sold out of LeMaitre Vascular (LMAT) in Q3 2017, closing a stake of 165,494 shares — an estimated $5.17M sold.

William Blair Investment Management first reported a position in LMAT in Q3 2015 and held it in 8 quarters. The position peaked at $9.35M in Q3 2016. 148 funds tracked by Wall St. Rank hold LMAT as of Q3 2017.

  • William Blair Investment Management reported no remaining LeMaitre Vascular position as of Q3 2017 after selling out during the quarter.
  • William Blair Investment Management sold 165,494 LeMaitre Vascular shares in Q3 2017, an estimated $5.17M.
  • William Blair Investment Management first reported a position in LeMaitre Vascular in Q3 2015 and held it in 8 quarters.
  • William Blair Investment Management's LeMaitre Vascular position peaked at $9.35M in Q3 2016.
  • 148 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2017.

Based on William Blair Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.